vivoVerse
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3303 Northland Dr Ste 308, Austin, Texas...Website
www.vivoverse.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About vivoVerse
vivoVerse, LLC is a biotechnology company headquartered in Austin, Texas, that provides high-throughput whole-organism screening for toxicology and safety endpoints. The company specializes in nematode imaging solutions using C. elegans model systems, offering the vivoScreen automated screening platform and patented vivoChip microfluidic technology for high-resolution, high-content data collection. Its services include the vivoDART AI-assisted Developmental and Reproductive Toxicity assay, which enables multiparametric toxicity analysis. vivoVerse serves the pharmaceutical, agrichem, petrochemical, and natural products industries to help identify safer chemicals and prioritize candidate compounds during development.Explore more
vivoVerse Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is vivoVerse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when vivoVerse launches new products
Click to see if vivoVerse had a recent Job posting/layoffs
Check out if vivoVerse is spiking on competitors!
Funding: Get notified immidiatlly once vivoVerse has new funding data
Congratulate Masked Content for being promoted to Masked Content at vivoVerse
Check if vivoVerse has recently received funding, and reach out quickly before it becomes old news!
vivoVerse, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on vivoVerse recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to vivoVerse
Compare insights from companies similar to vivoVerse, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
vivoVerse is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
vivoVerse is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about vivoVerse.
vivoVerse Tech Stack
A closer look at the technologies used by vivoVerse
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
recevied an award of $996,687 on August 1, 2023 by HHS NIH with an award end date of July 31, 2025. This award will support efforts focused on developing and validating a high-throughput DART assay using the vivoChip and Caenorhabditis elegans, to improve safety predictions by analyzing diverse genetic backgrounds and demonstrating its efficacy compared to traditional mammalian models.
Business Intelligence, Quality Assurance, Analytics & Insights, Safety, Laboratory Operations, Operations
Funding
Project
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding vivoVerse
Sign Up For FreeTo access detailed company insights
vivoVerse, LLC is a biotechnology company headquartered in Austin, Texas, that provides high-throughput whole-organism screening for toxicology and safety endpoints. The company specializes in nematode imaging solutions using C. elegans model systems, offering the vivoScreen automated screening platform and patented vivoChip microfluidic technology... Read More
